In these conditions the n-3 PUFA groups received EPA (270 mg/kg) and DHA (180 mg/kg). == Model of partial ischemia-reperfusion injury == At day 8 after EPA plus DHA supplementation, rats were anaesthetized with intraperitoneal (1 ml/kg) zolazepam chlorhydrate (25 mg/ml) and tiletamine chlorhydrate (25 mg/ml) (Zoletil 50; Virbac S/A, Carros, France) and IR was induced by temporarily occluding the blood supply to the left and median lobes of the liver by means of a Schwartz clip (Fine Science Tools, Vancouver, BC, Canada) for 1 h, followed by up to 20 h of reperfusion, as previously described[11]. IR-injury (1 h of ischemia and 20 h of reperfusion) or sham Vanoxerine laparotomy (controls) in male Sprague Dawley rats. Animals were previously supplemented for 7 days with encapsulated fish oil (General Nutrition Corp., Pittsburg, PA) or isovolumetric amounts of saline (controls). Normalization of IR-altered parameters of liver injury (serum transaminases and liver morphology) was achieved by dietary n-3 PUFA supplementation. EPA and DHA suppression of the early IR-induced NF-B activation was paralleled by generation of PPAR-/NF-Bp65 complexes, in concomitance with normalization of the IR-induced IB- phosphorylation. PPAR- activation by n-3 PUFA was evidenced by enhancement in the expression of the PPAR–regulated Acyl-CoA oxidase (Acox) and Carnitine-Palmitoyl-CoA transferase I (CPT-I) genes. Consistent with these findings, normalization of IR-induced expression and serum levels of NF-B-controlled cytokines IL-l and TNF- was observed at 20 h of reperfusion. Taken together, these findings point to an antagonistic effect of PPAR- on NF-B-controlled transcription Rabbit polyclonal to Amyloid beta A4.APP a cell surface receptor that influences neurite growth, neuronal adhesion and axonogenesis.Cleaved by secretases to form a number of peptides, some of which bind to the acetyltransferase complex Fe65/TIP60 to promote transcriptional activation.The A of pro-inflammatory mediators. This effect is associated with the formation of PPAR-/NF-Bp65 complexes and enhanced cytosolic IB- stability, as major preconditioning mechanisms induced by n-3 PUFA supplementation against IR liver injury. == Introduction == Human liver resections involving vascular occlusion to reduce blood loss may lead to severe hepatic dysfunction, with irreversible organ damage due to hepatocyte and endothelial cell death[1]. Taking into account that vascular occlusion of the liver or ischemia (I), followed by its restoration during reperfusion (R) occurs during surgical manoeuvres such as transplantation, tissue resection under inflow occlusion (Pringle manoeuvre), and hypoperfusion Vanoxerine shock, several preconditioning strategies affording resistance to liver IR injury have been evaluated[2]. In this respect, we have established that dietary supplementation with the n-3 polyunsaturated fatty acids (n-3 PUFA) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are highly concentrated in fish oils, affords significant prevention of liver injury induced by IR in the rat, thus representing a novel preconditioning strategy[3]. Fish oil supplementation significantly enhanced the hepatic content of n-3 PUFAs, with diminution in the n-6/n-3 PUFA ratio, suppression of IR-induced oxidative stress, and recovery of IR-altered pro-inflammatory cytokine response and nuclear factor-B (NF-B) functionality[3]. In the Vanoxerine latter case, n-3 PUFA supplementation normalized both the early increase (3 h) and late diminution (20 h) in NF-B DNA activity induced by IR[3]. As a result of their incorporation into Vanoxerine cell phospholipids, EPA and DHA exert a significant inhibition of the metabolism of the n-6 PUFA arachidonic acid (AA), thus decreasing the release of AA-derived pro-inflammatory eicosanoids[4]. In addition, EPA and DHA have been shown to generate a group of lipid mediators called resolvins (E- and D-series) and protectins with potent anti-inflammatory and inflammation resolution properties[4],[5]. Studies in experimental models of liver injury have reported beneficial actions of n-3 PUFA-derived resolvins and protectins, preventing liver DNA damage and oxidative stress, with significant reduction in necroinflammatory liver injury and hepatic steatosis[6],[7]. Although these mediators might explain many of the anti-inflammatory actions of n-3 fatty acids, eicosanoid-independent actions including EPA and DHA effects on transcription factors regulating inflammatory gene expression such as NF-B, should be considered. Supporting this view are the data showing the decreasing effect of n-3 PUFAs on the production of pro-inflammatory cytokines regulated by NF-B[8]. NF-B is an essential factor with dual intracellular effects, playing a role in acute cellular stress responses by inducing proteins affording survival[9], or acting as a pro-inflammatory transcription factor by upregulating the expression of pro-inflammatory cytokines and adhesion molecules[10]. Changes Vanoxerine in NF-B DNA binding activity are main mediators in liver IR injury, as pointed by its biphasic activation pattern in liver IR injury in the rat. An early peak (0.53 h after reperfusion) due to the nuclear translocation of NF-B p50/p65 heterodimers correlates with.
